Analytical Data
-
基因名
alphaIC
- Application
-
别名
Dermonecrotic toxin LamSicTox-alphaIC1; EC 4.6.1.-; Phospholipase D; PLD; Sphingomyelin phosphodiesterase D; SMD; SMase D; Sphingomyelinase D; Fragment
-
种属
Loxosceles amazonica
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
C0JAZ9
-
表达区间
1-273aa
-
分子量
34.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AlphaIC recombinant proteins are an important focus of research due to their potential applications in various fields such as medicine, biotechnology, and agriculture. The AlphaIC family consists of proteins that play crucial roles in cellular processes, including signal transduction, cell growth, and immune response. The study of these proteins has gained traction as scientists seek to understand their structure-function relationships and the mechanisms underlying their biological activities. Advances in recombinant DNA technology have made it feasible to produce AlphaIC proteins in vitro, allowing for the detailed characterization of their functions and interactions. This research is particularly relevant in therapeutic contexts, where AlphaIC proteins may be leveraged for drug development, including targeted therapies for diseases such as cancer and autoimmune disorders. Furthermore, understanding the properties of these proteins can lead to innovations in crop improvement and pest resistance. As a result, the investigation of AlphaIC recombinant proteins is not only fundamental for basic biological research but also has significant implications for developing novel health and agricultural solutions.
